# Talaris Therapeutics, Inc. — Form D

Talaris Therapeutics, Inc. of LOUISVILLE, KY, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-07. The offering totals $115.0M, of which $115.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-10-07
- Form: D
- Accession: 0001827506-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $115.0M
- Amount sold: $115.0M
- Investors: 24
- Date of first sale: 2020-09-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-377389

## Issuer

- Name: Talaris Therapeutics, Inc.
- CIK: 0001827506
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 201 E. JEFFERSON ST., SUITE 110B, LOUISVILLE, KY, 40202
- Phone: 502-569-1059

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Sandip Agarwala | Director | Louisville, KY |
| Nick Galakatos | Director | Louisville, KY |
| Suzanne Ildstad | Director | Louisville, KY |
| Geoff MacKay | Director | Toronto, A6 |
| Mark McDade | Director | South San Francisco, CA |
| Francois Nader | Director | Palo Alto, CA |
| Scott Requadt | Director | Louisville, KY |
| Suzanne Ildstad | Executive Officer | Louisville, KY |
| Scott Requadt | Executive Officer | Louisville, KY |

## More

- [CIK 1827506 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1827506&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001827506-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.